View of Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss and Cardiovascular Protection in Obesity and Type2 Diabetes: A Systematic Review and Meta-Analysis

Return to Article Details Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss and Cardiovascular Protection in Obesity and Type2 Diabetes: A Systematic Review and Meta-Analysis Download Download PDF